Inoue Takayuki Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. 2014/04
2.
Case report
Primary follicular lymphoma of the spleen incidentally found in a patient with alcohol- and hepatitis C-related liver cirrhosis. 2014/12
3.
Original article
Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
4.
Original article
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
5.
Case report
Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. 2016/02
6.
Case report
Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation 2017/05
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
9.
Original article
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
10.
Case report
Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. 2019/10
11.
Original article
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
Hematopoietic stem cell transplantation using a related donor not sharing HLA-haplotype (Oral presentation,General Lecture) 2015/03/06
2.
Maturation of dendritic cells restrained by host Foxp3+CD4+regulatory T cells: the critical role in the induction of graft-veusus-host reaction after experimental BMT. (Oral presentation,General Lecture) 2015/03/06
3.
A case report with MDS who underwent haploindentical transplantation after umbilical cord blood transplantation with Mixed cheimerism state over a long period of time. (Poster presentation,General Lecture) 2016/03/04
4.
Allogeneic Stem Cell Transplantation for X-linked agammaglobulinemia as a model of the reconstitution of humoral immunity (Oral presentation,General Lecture) 2016/03/04
5.
clinical outcomes of HLA haploidentical hematopoietic stem cell transplantation in patients with Philadelphia Chromosome positive Acute Lymphoblastic Leukemia in our institute (Oral presentation,General Lecture) 2016/03/04
6.
A case of cerebral toxoplasmosis and EBV-associated post-transplant lymphoproliferative disorder of the central nervous system following allogeneic hematopoietic stem cell transplantation (Poster presentation,General Lecture) 2017/03/02
7.
Effective Desensitization of Donor-specific HLA Antibodies Using Platelet Transfusion Bearing Targeted HLA in a Case of HLA-mismatched Allogeneic Stem Cell Transplantation (Poster presentation,General Lecture) 2017/03/02
8.
One example of acute myeloid leukemia for severe hepatic dysfunction due to acute GVHD who underwent living donor liver transplantation from hematopoietic stem cell donor (Poster presentation,General Lecture) 2017/03/02
9.
Study on citrate intozication during peripheral blood stem cell harvesting (Poster presentation,General Lecture) 2017/03/02
10.
Association beteween plasma concentration of antithymocyte globulin(ATG) and acute graft versus host disease(GVHD) granding on haploidentical hematopoietic stem cell transplantation (Oral presentation,General Lecture) 2017/03/04
11.
Prognostic value of WT1 on HLA-haploidentical RIST for non-remission leukemia (Oral presentation,General Lecture) 2018/02/02
12.
Prediction of hemorrhagic cystitis using antibody to ADV type11 and prophylastic value of cidofovir (Oral presentation,General Lecture) 2018/02/03
13.
HLA haploidentical transpantation in AYAs (Oral presentation,General Lecture) 2019/03/08
14.
Isohemagglotinin production after minor ABO-incompatible peripheral blood stem cell transplantation (Oral presentation,General Lecture) 2019/03/08
15.
Steroid-resistant,homeostatically-proliferationg donor T cells in BM suppresses GVHD preserving GVL (Oral presentation,General Lecture) 2019/03/08
16.
Secondary malignancies after hematopoietic stem cell transplantation in Hyogo college of medicine (Oral presentation,General Lecture) 2019/03/09
17.
Phamacokinetics of cidofovir in Japanese patients receiving hematopoietic stem cell transplantation (Oral presentation,General Lecture) 2020/03/06